Category: Press Release - Page 22 - Psychedelic Alpha

Read more about the article Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Post published:March 28, 2023
Post category:Press Release

Read more about the article Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics

Post published:March 28, 2023
Post category:Press Release

Read more about the article Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Post published:March 27, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

Post published:March 27, 2023
Post category:Press Release

Read more about the article Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program

Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program

Post published:March 27, 2023
Post category:Press Release

Read more about the article atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights

atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights

Post published:March 24, 2023
Post category:Press Release

Read more about the article Psyence Group Announces Cantheon Capital Private Placement

Psyence Group Announces Cantheon Capital Private Placement

Post published:March 23, 2023
Post category:Press Release

Read more about the article Field Trip Health & Wellness Obtains CCAA Protection

Field Trip Health & Wellness Obtains CCAA Protection

Post published:March 22, 2023
Post category:Press Release

Read more about the article Promise of BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article

Promise of BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article

Post published:March 22, 2023
Post category:Press Release

Read more about the article Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Post published:March 22, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.